Epidemic Spread of Pandoraea apista, a New Pathogen Causing Severe Lung Disease in Cystic Fibrosis Patients

Pediatric Pulmonology

Volumn 36, Issue 5, 2003, Pages 439-446

  Jørgensen, Inger Merete ^a   Johansen, Helle Krogh ^a   Frederiksen, Birgitte ^a   Pressler, Tacjana ^a   Hansen, Annelise ^a   Vandamme, Peter ^b   Høiby, Niels ^a   Koch, Christian ^a  

^a Rigshospitalet   (Denmark)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CEFTAZIDIME; COTRIMOXAZOLE; DOXYCYCLINE;

ADULT; ANTIBIOTIC THERAPY; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM STAINING; HOSPITALIZATION; HUMAN; ISOLATION PROCEDURE; PANDORAEA APISTA; PATIENT CARE; PRIORITY JOURNAL; SPUTUM SMEAR;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BACTERIAL INFECTIONS; BETAPROTEOBACTERIA; COHORT STUDIES; COMORBIDITY; CYSTIC FIBROSIS; DENMARK; DISEASE OUTBREAKS; DISEASE TRANSMISSION, HORIZONTAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; OPPORTUNISTIC INFECTIONS; RESPIRATORY TRACT INFECTIONS; SPUTUM; TREATMENT OUTCOME;

EID: 0142094574     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10383     Document Type: Article

References (29)

1. Coenye T, Falsen E, Hoste B, Ohlén M, Goris J, Govan JRW, Gillis M, Vandamme P. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol 2000;50:887-899.
2. Daneshvar MI, Hollis DG, Steigerwalt AG, Whitney AM, Spangler L, Douglas MP, Jordan JG, MacGregor JP, Hill BC, Tenover FC, Brenner DJ, Weyant RS. Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies. J Clin Microbiol 2001;39:1819-1826.
3. Coenye T, Goris J, Spilker T, Vandamme P, LiPuma JJ. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol 2002;40:2052-2069.
4. Moore JE, Reid A, Millar BC, Jiru X, McCaughan J, Goldsmith CE, Collins J, Murphy PG, Elborn JS. Pandoraea apista isolated from a patient with cystic fibrosis: problems associated with laboratory identification. Br J Biomed Sci 2002;59:164-166.
5. Høiby N, Frederiksen B. Microbiology of cystic fibrosis. In: Hodson ME, Geddes DM, editors. Cystic fibrosis. London: Arnold; 2000. p 83-107.
6. Pedersen SS, Koch C, Høiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis center. J Antimicrob Chemother 1986;17:505-516.
7. Frederiksen B, Lanng S, Koch C, Hoiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 1996;21:153-158.
8. Ojeniyi B, Frederiksen B, Hoiby N. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000;29:177-181.
9. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-335.
10. Frederiksen B, Koch C, Hoiby N. Changing epidemiologiy of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999;28:159-166.
11. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol Microbiol Scand [C] [Suppl] 1977;262:3-96.
12. Høiby N, Koch C. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax 1990;45:881-884.
13. Weyany RS, Moss CW, Weaver RE, Hollis DG, Jordan JG, Cook EC, Daneshvar MI, editors. Identification of unusual pathogenic Gram-negative aerobic and facultatively anaerobic bacteria. Baltimore: Williams and Wilkins; 1996. p 560-561.
14. Høiby H, Collins MT, Espersen F, Hertz JB, Hoff GE, Schiøtz PO. Taxonomic application of crossed immunoelectrophoresis. Int J Syst Bacteriol 1987;37:229-240.
15. Ojeniyi B, Høiby N, Rosdahl VT. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients. Acta Pathol Microbiol Immunol Scand 1991;99:492-498.
16. Struelens MJ. Members of European Study Group on Epidemiological Markers (ESGEM) of European Society for Clinical Microbiology and Infectious Diseases (ESCMID). Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin Microbiol Infect 1996;2:2-11.
17. Høiby N, Johansen HK, Moser C, Song Z, Ciofu O, Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 2001;3:23-35.
18. Johansen HK, Kovesi TA, Koch C, Corey M, Høiby N, Levison H. Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen. Pediatr Pulmonol 1998;26:89-96.
19. Skov M, Main KM, Sillesen IB, Müller J, Koch C, Lanng S. Iatrogenic adrenal insufficiency as side-effect to combined treatment of itraconazole and budesonide. Eur Respir J 2002;20:127-133.
20. Linthoudt H, Van Raemdonck D, Lerut T, Demedts M, Verleden G. The association of itraconazole and methylprednisolone may give rise to important steroid-related side effects. J Heart Lung Transplant 1996;15:1165.
21. Koch C, Høiby N. Diagnosis and treatment of cystic fibrosis. Respiration 2000;67:239-247.
22. Grothues D, Koopmann U, von der Hardt H, Tümmler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol 1988;26:1973-1977.
23. Høiby N, Pedersen SS. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand 1989;78:395-404.
24. Li Puma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Personto-person transmission of Pseudomonas cepacia between persons with cystic fibrosis. Lancet 1990;336:1094-1096.
25. Pegues DA, Carson LA, Tablan OC, FitzSimmons SC, Roman SB, Miller JM, Jarvis WR. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. J Pediatr 1994;124:694-702.
26. Govan JRW, Brown PH, Maddison J, Doherty C, Nelson JW, Dodd M, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-19.
27. Garred P, Pressler T, Madsen H-O, Frederiksen B, Svejgaard A, Høiby N, Schwartz M, Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999;104:431-437.
28. Fauroux B, Delaisi B, Clement A, Saizou C, Moissenet D, Truffot-Pernot C, Tournier G, Vu-Thien H. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J 1997;16:354-358.
29. Sanguinetti M, Ardito F, Fiscarelli E, La-Sorda M, D'Argenio P, Ricciotti G, Fadda G. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 2001;39:816-819.